The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation between PI3K/PTEN/AKT/mTOR pathway genetic variations and clinical outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.
Alberto Fusi
No relevant relationships to disclose
Katharina Pfisterer
No relevant relationships to disclose
Konrad Friedrich Klinghammer
No relevant relationships to disclose
Maren Knoedler
No relevant relationships to disclose
Anika Nonnenmacher
No relevant relationships to disclose
Ulrich Keilholz
No relevant relationships to disclose